AwardedSpainGoods€373,417
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de Medicamentos para tratar la HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISPLIDEMIA MIXTA CON INHIBIDORES DE PCSK9 de la Corporació de Salut del Maresme i La Selva
- Published
- Published 5 August 2025
Overview
Adjudicación del Contrato Basado de la Corporació de Salut del Maresme i La Selva derivado del Acuerdo Marco del Suministro de Medicamentos para tratar la HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISPLIDEMIA MIXTA CON INHIBIDORES DE PCSK9 tramitado por el Consorci de Salut i d’Atenció Social de Catalunya
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €373,417
- Procedure
- Open
- Published
- 5 August 2025
Pharmaceutical productsVarious medicinal products
Award outcome
- Award date
- 4 August 2025
- Contract period
- 4 August 2025 → 30 July 2026
- AMGEN, S,A,
- Sanofi Aventis, S,A,
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 August 2025
Contracting authority
Corporació de Salut del Maresme i la Selva
Procuring entityCalella, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.